It’s inspiring to see the great ideas that researchers bring to us to fund.
But we also acknowledge the barriers and bottlenecks faced by people and fields. And a big part of our vision is to remove these and even open new fields of research.
Take the development of tools, methodologies and technologies as an example. They’re often seen as hypothesis generating, rather than hypothesis driven. In the past we’ve struggled to support them.
Our Discovery Research Platforms are one example of how we’re changing that through longer-term funding. The Platforms bring together researchers, teams and collaborators to address a range of practical, technological and methodological barriers that are holding up progress.
In fields such as bioimaging and genomics, where Wellcome has long-standing interest and investment, we’re directing targeted funding to give those fields a boost. We’re working in this way to address challenges in these fields, which might range from high infrastructure costs through to technical hurdles like data processing – and much more.
We also remain committed to a small number of long-term, large-scale investments, including the Wellcome Sanger Institute, the Francis Crick Institute and UK Biobank.